Bosak V - Search Results

1

MCP-1 -2518 A/G single nucleotide polymorphism in Slovak patients with systemic sclerosis.

Navratilova Z, Lukac J, Mrazek F, Kriegova E, Bucova M, Bosak V, Petrek M. Navratilova Z, et al. Among authors: bosak v. Mediators Inflamm. 2008;2008:204063. doi: 10.1155/2008/204063. Mediators Inflamm. 2008. PMID: 18528529 Free PMC article.

2

Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis.

Hutyrová B, Lukác J, Bosák V, Buc M, du Bois R, Petrek M. Hutyrová B, et al. Among authors: bosak v. J Rheumatol. 2004 Jan;31(1):81-4. J Rheumatol. 2004. PMID: 14705223

3

CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjögren's syndrome.

Petrek M, Cermáková Z, Hutyrová B, Miceková D, Drábek J, Rovensky J, Bosák V. Petrek M, et al. Among authors: bosak v. Clin Exp Rheumatol. 2002 Sep-Oct;20(5):701-3. Clin Exp Rheumatol. 2002. PMID: 12412204

4

[The major histocompatibility system in man and systemic lupus erythematosus. (SLE). II. HLA antigens in SLE in the Slovak population].

Bosák V, Zitnan D, Lukác J, Rovenský J, Cebecauer L. Bosák V, et al. Fysiatr Revmatol Vestn. 1984 Apr;62(2):65-70. Fysiatr Revmatol Vestn. 1984. PMID: 6540233 Slovak. No abstract available.

5

Deficiency of C2, the second complement component, in the family of a patient with SLE-like syndrome: the first case of hereditary C2 deficiency in Czechoslovakia.

Starsia Z, Zitnan D, Loos M, Stefanovic J, Bosák V, Niks M, Tomanová H, Lukác J, Lulovicová M. Starsia Z, et al. Among authors: bosak v. Haematologia (Budap). 1987;20(4):215-20. Haematologia (Budap). 1987. PMID: 3428724

6

Clinical and immunological characterization of systemic lupus erythematosus in patients with circulating interferon and migration inhibitory factor.

Rovenský J, Bosák V, Zitnan D, Lackovic V, Borecký L, Pekárek J, Svejcar J, Lukác J, Matoková M. Rovenský J, et al. Among authors: bosak v. Int J Clin Pharmacol Res. 1984;4(6):465-8. Int J Clin Pharmacol Res. 1984. PMID: 6085328

7

NFkappaB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complications.

Romzova M, Hohenadel D, Kolostova K, Pinterova D, Fojtikova M, Ruzickova S, Dostal C, Bosak V, Rychlik I, Cerna M. Romzova M, et al. Among authors: bosak v. Hum Immunol. 2006 Sep;67(9):706-13. doi: 10.1016/j.humimm.2006.05.006. Epub 2006 Jun 22. Hum Immunol. 2006. PMID: 17002901

8

Coexistence of ochronosis and rheumatoid arthritis: a cause of delay in diagnosis and treatment.

Rovenský J, Letkovská A, Schumacher HR, Urbánek T, Bosák V. Rovenský J, et al. Among authors: bosak v. J Clin Rheumatol. 2000 Aug;6(4):214-7. J Clin Rheumatol. 2000. PMID: 19078474

9

[HLA system antigens in gouty arthritis].

Bosák V, Bosmanský K, Nyulassy S. Bosák V, et al. Fysiatr Revmatol Vestn. 1983 Jun;61(3):163-5. Fysiatr Revmatol Vestn. 1983. PMID: 6684089 Slovak. No abstract available.

10

[Beta-2-microglobulin and ankylosing spondylitis].

Mateicka F, Cebecauer L, Bosák V, Bosmanský K, Ondrasík M. Mateicka F, et al. Among authors: bosak v. Cas Lek Cesk. 1990 Apr 13;129(15):457-61. Cas Lek Cesk. 1990. PMID: 2189571 Slovak.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page